Kyntra Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	117.98	50.48	81.55	155.7	171.22	678.39
Short-Term Investments	-	-	121.9	266.31	233.97	8.14
Cash & Short-Term Investments	117.98	50.48	203.45	422.01	405.19	686.54
Cash Growth	-9.95%	-75.19%	-51.79%	4.15%	-40.98%	28.62%
Accounts Receivable	0.12	0.48	5.12	16.3	25.4	41.88
Other Receivables	10	28.5	28.5	-	-	-
Receivables	10.12	28.98	33.62	16.3	25.4	41.88
Inventory	3.86	3.16	17.17	40.44	31.02	16.53
Prepaid Expenses	0.77	1.9	4.86	9.73	7.38	8.35
Other Current Assets	0.7	111.99	72.46	4.35	5.07	1.81
Total Current Assets	133.42	196.51	331.56	492.83	474.06	755.11
Property, Plant & Equipment	-	0.1	69.86	100.93	120.15	65.3
Long-Term Investments	3.04	-	-	9.41	171.62	2.97
Other Long-Term Assets	0.56	17.92	22.11	6.92	7.99	3.46
Total Assets	137.01	214.53	423.53	610.09	773.82	826.84
Accounts Payable	5.09	5.06	15.78	30.76	26.1	24.79
Accrued Expenses	8.9	13.02	40.39	130.19	121.62	89.29
Current Portion of Leases	-	-	12.65	10.33	10.96	13.52
Current Unearned Revenue	6.67	27.75	18.39	12.74	19.03	21.68
Other Current Liabilities	15.31	87.48	130.46	89.55	47.79	13.91
Total Current Liabilities	35.97	133.31	217.67	273.56	225.5	163.19
Long-Term Debt	19.47	90.1	89.7	16.92	17.61	18.7
Long-Term Leases	-	0.07	65.14	79.73	88.78	26.24
Long-Term Unearned Revenue	63.99	173.57	208.97	235.06	186.8	138.47
Other Long-Term Liabilities	0.1	1.11	4.26	6.3	26.02	38.79
Total Liabilities	119.53	398.16	585.73	611.57	544.71	385.39
Common Stock	1.01	1.01	0.99	0.94	0.93	0.91
Additional Paid-In Capital	1,676	1,669	1,644	1,541	1,476	1,400
Retained Earnings	-1,692	-1,889	-1,842	-1,558	-1,264	-974.01
Comprehensive Income & Other	-2.21	-5.73	-6.88	-5.72	-4.16	-4.5
Total Common Equity	-17.03	-225.6	-204.17	-21.45	209.15	422.18
Minority Interest	34.51	41.97	41.97	19.97	19.97	19.27
Shareholders' Equity	17.49	-183.64	-162.2	-1.48	229.11	441.45
Total Liabilities & Equity	137.01	214.53	423.53	610.09	773.82	826.84
Total Debt	19.47	90.17	167.48	106.98	117.35	58.46
Net Cash (Debt)	98.5	-39.69	35.97	315.03	287.84	628.08
Net Cash Growth	159.05%	-	-88.58%	9.45%	-54.17%	35.49%
Net Cash Per Share	24.38	-9.92	9.24	84.16	77.92	174.75
Filing Date Shares Outstanding	4.05	4.04	3.95	3.77	3.72	3.66
Total Common Shares Outstanding	4.05	4.04	3.95	3.77	3.72	3.66
Working Capital	97.45	63.2	113.89	219.26	248.56	591.92
Book Value Per Share	-4.21	-55.89	-51.68	-5.69	56.29	115.42
Tangible Book Value	-17.03	-225.6	-204.17	-21.45	209.15	422.18
Tangible Book Value Per Share	-4.21	-55.89	-51.68	-5.69	56.29	115.42
Machinery	-	-	32.82	46.5	43.51	42.13
Construction In Progress	-	-	-	0.2	2.42	0.76
Leasehold Improvements	-	-	84.92	102.58	103.35	102.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.